Date: Tuesday 26 Aug 2014
LONDON (ShareCast) - Bioquell: N+1 Singer upgrades from hold to buy with an unchanged target price of 112p. Investec cuts target price from 133p to 98p, while upgrading from hold to add.
Circle Oil: Investec moves target price from 50p to 70p and maintains a buy recommendation.
Clinigen Group: N+1 Singer ups target price from 439p to 488p and keeps a buy recommendation.
Greene King: Numis upgrades from add to buy with a target price of 975p.
Kazakhmys: Canaccord Genuity shifts target price from 295p to 300p upgrading from sell to hold.
Phoenix Group: Barclays upgrades to equal-weight.
Plexus: Numis moves target price from 364p to 372p and upgrades from add to buy.
Polymetal: Canaccord Genuity ups target price from 540p to 565p and retains a hold recommendation.
SIG: UBS lowers target price from 230p to 220p leaving its buy recommendation unchanged.
Synthomer: Deutsche Bank raises target price from 225p to 260p upgrading to buy.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 15.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 28.60p |
52 Week Low | 2.60p |
Volume | 0 |
Shares Issued | 105.39m |
Market Cap | £16.07m |
RiskGrade | 216 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Latest | Previous | |
---|---|---|
Special | Final | |
Ex-Div | 21-Mar-19 | 05-Nov-15 |
Paid | 08-Apr-19 | 16-Dec-15 |
Amount | 1.00p | 1.75p |
CEO | Bernard van Bilderbeek |
Finance Director | Graham Stevens |
You are here: research